126 related articles for article (PubMed ID: 9750252)
21. The analysis of correlated panel data using a continuous-time Markov model.
Lee EW; Kim MY
Biometrics; 1998 Dec; 54(4):1638-44. PubMed ID: 9883555
[TBL] [Abstract][Full Text] [Related]
22. Design and analysis of group sequential clinical trials with multiple primary endpoints.
Kosorok MR; Yuanjun S; DeMets DL
Biometrics; 2004 Mar; 60(1):134-45. PubMed ID: 15032783
[TBL] [Abstract][Full Text] [Related]
23. Changing frequency of interim analysis in sequential monitoring.
Lan KK; DeMets DL
Biometrics; 1989 Sep; 45(3):1017-20. PubMed ID: 2790114
[TBL] [Abstract][Full Text] [Related]
24. The behavior of the P-value when the alternative hypothesis is true.
Hung HM; O'Neill RT; Bauer P; Köhne K
Biometrics; 1997 Mar; 53(1):11-22. PubMed ID: 9147587
[TBL] [Abstract][Full Text] [Related]
25. Frequentist evaluation of group sequential clinical trial designs.
Emerson SS; Kittelson JM; Gillen DL
Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678
[TBL] [Abstract][Full Text] [Related]
26. Monitoring pairwise comparisons in multi-armed clinical trials.
Follmann DA; Proschan MA; Geller NL
Biometrics; 1994 Jun; 50(2):325-36. PubMed ID: 8068834
[TBL] [Abstract][Full Text] [Related]
27. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
Lachin JM
Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
[TBL] [Abstract][Full Text] [Related]
28. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
Byington RP
Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
[TBL] [Abstract][Full Text] [Related]
29. Multiple imputation for early stopping of a complex clinical trial.
Betensky RA
Biometrics; 1998 Mar; 54(1):229-42. PubMed ID: 9544518
[TBL] [Abstract][Full Text] [Related]
30. Confidence intervals following group sequential tests in clinical trials.
Kim K; DeMets DL
Biometrics; 1987 Dec; 43(4):857-64. PubMed ID: 3427170
[TBL] [Abstract][Full Text] [Related]
31. Estimating reliability and generalizability from hierarchical biomedical data.
Molenberghs G; Laenen A; Vangeneugden T
J Biopharm Stat; 2007; 17(4):595-627. PubMed ID: 17613644
[TBL] [Abstract][Full Text] [Related]
32. Current controversies in data monitoring for clinical trials.
Pocock SJ
Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
[TBL] [Abstract][Full Text] [Related]
33. Repeated confidence intervals for adaptive group sequential trials.
Mehta CR; Bauer P; Posch M; Brannath W
Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
[TBL] [Abstract][Full Text] [Related]
34. Tests for homogeneity of the risk difference when data are sparse.
Lipsitz SR; Dear KB; Laird NM; Molenberghs G
Biometrics; 1998 Mar; 54(1):148-60. PubMed ID: 9544513
[TBL] [Abstract][Full Text] [Related]
35. Group sequential comparison of changes: ad-hoc versus more exact method.
Lee JW; DeMets DL
Biometrics; 1995 Mar; 51(1):21-30. PubMed ID: 7766776
[TBL] [Abstract][Full Text] [Related]
36. Beta Blocker Heart Attack Trial: design features.
Control Clin Trials; 1981 Dec; 2(4):275-85. PubMed ID: 6120793
[TBL] [Abstract][Full Text] [Related]
37. Tests for treatment group differences in the hazards for survival, before and after the occurrence of an intermediate event.
Bebchuk JD; Betensky RA
Stat Med; 2005 Feb; 24(3):359-78. PubMed ID: 15568187
[TBL] [Abstract][Full Text] [Related]
38. Optimal spending functions for asymmetric group sequential designs.
Anderson KM
Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
[TBL] [Abstract][Full Text] [Related]
39. The B-value: a tool for monitoring data.
Lan KK; Wittes J
Biometrics; 1988 Jun; 44(2):579-85. PubMed ID: 3390511
[TBL] [Abstract][Full Text] [Related]
40. Estimation of a secondary parameter in a group sequential clinical trial.
Gorfine M
Biometrics; 2001 Jun; 57(2):589-97. PubMed ID: 11414589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
